[1]
Sur, D., Havasi, A., Lungulescu, C., Volovat, S., Burz, C. and Irimie, A. 2022. Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports. (May 2022). DOI:https://doi.org/10.15386/mpr-2120.